| Announce Date | 11/10/2025 |
| EPS Normalized Actual | $-0.23347 (Miss by $-0.39347) |
| EPS GAAP Actual | $-0.23347 (Miss by $-0.39347) |
| Revenue Actual | $0.160511B |
| Revenue Surprise | Beat by $160.511M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.12333 |
| EPS GAAP Estimate | $0.12333 |
| Revenue Estimate | $0.127914667B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.92 | 13.52 | 0.90663 | 0.93337 | 1 |
| Dec 2028 | 0.62 | 20.06 | 0.62 | 0.62 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.23 | -0.23 | 0.160511B | 29.44% | 160.51M |
| FQ2 2025 (Jun 2025) | 0.36 | 0.36 | 0.118623B | -24.27% | 118.62M |
| FQ1 2025 (Mar 2025) | 1.54 | 1.54 | 0.09629B | -67.26% | 96.29M |
| FQ4 2024 (Dec 2024) | 1.1 | 1.1 | 0.137696B | 8.06% | 137.7M |
| FQ3 2024 (Sep 2024) | -3.41 | -3.41 | 0.113255B | 45.35% | 113.26M |
| FQ2 2024 (Jun 2024) | 0.27 | 0.27 | 0.147416B | 39.9% | 147.42M |
| FQ1 2024 (Mar 2024) | -0.39 | -0.39 | 0.161058B | 49.71% | 161.06M |
| FQ4 2023 (Dec 2023) | -0.0001 | -0.0001 | 0.126604B | -1.88% | 126.6M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
0.12333
Consensus Revenue Estimates
0.127914667B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.24 | -- | 0.22157 | 0.26684 | 1 |
| FQ3 2027 (Sep 2027) | 0.25 | -- | 0.2308 | 0.27796 | 1 |
| FQ2 2027 (Jun 2027) | 0.23 | -- | 0.21234 | 0.25572 | 1 |
| FQ1 2027 (Mar 2027) | 0.17 | -- | 0.15694 | 0.18901 | 1 |
| FQ4 2026 (Dec 2026) | 0.24 | -- | 0.22157 | 0.26684 | 1 |
| FQ3 2026 (Sep 2026) | 0.19667 | 216.95 | 0.18157 | 0.21866 | 1 |
| FQ2 2026 (Jun 2026) | 0.16667 | -116 | 0.15387 | 0.18531 | 1 |
| FQ1 2026 (Mar 2026) | 0.12333 | -1148.68 | 0.11386 | 0.13712 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.43B | -- | 0.41B | 0.47B | 1 |
| FQ3 2027 (Sep 2027) | 0.39B | -- | 0.36B | 0.42B | 1 |
| FQ2 2027 (Jun 2027) | 0.35B | -- | 0.33B | 0.38B | 1 |
| FQ1 2027 (Mar 2027) | 0.31B | -- | 0.29B | 0.34B | 1 |
| FQ4 2026 (Dec 2026) | 0.18B | -- | 0.17B | 0.19B | 1 |
| FQ3 2026 (Sep 2026) | 0.16B | -3.03 | 0.15B | 0.17B | 1 |
| FQ2 2026 (Jun 2026) | 0.15B | 20.44 | 0.14B | 0.16B | 1 |
| FQ1 2026 (Mar 2026) | 0.13B | 24.72 | 0.13B | 0.13B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.23 | -0.23 | 100% | |
| FQ2 2025 (Jun 2025) | 0.36 | 0.36 | 100% | |
| FQ1 2025 (Mar 2025) | 1.54 | 1.54 | 100% | |
| FQ4 2024 (Dec 2024) | 1.1 | 1.1 | 100% | |
| FQ3 2024 (Sep 2024) | -3.41 | -3.41 | 100% | |
| FQ2 2024 (Jun 2024) | 0.27 | 0.27 | 100% | |
| FQ1 2024 (Mar 2024) | -0.39 | -0.39 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0001 | -0.0001 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.16B | $160.51M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.12B | $118.62M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.1B | $96.29M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.14B | $137.7M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.11B | $113.26M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.15B | $147.42M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.16B | $161.06M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.13B | $126.6M | 100% |